Skip to main content
Focused investors/ValueAct Capital

ValueAct Capital

As of Q2 2026, ValueAct Capital reported 18 long-equity positions worth $5.63B in aggregate.

Copy-investor backtest

Latest quarter
+11.81%
1-year
-6.13%
3-year
+68.78%
5-year
+54.42%
3-year vs S&P 500
-4.46%
5-year vs S&P 500
-19.26%
5-year top 5
+37.05%

Return from mechanically copying the disclosed 13F equity portfolio after each filing and rebalancing at the next. The vs S&P 500 figures subtract SPY over that manager's own rebalance dates, so both sides cover the same days; both are price return, excluding dividends. Method & limitations.

Get email alerts when ValueAct Capital files a new 13F — sign in or create a free account.

Updated 2026-06-06 from SEC 13F data.

Live quotes available for 12 of 17 rows. Rows without a quote are marked unavailable.

1CCITIGROUP15.25%Add +55.4%25,175,500$1.68B$66.92No quote
2BFHALLIANCE DATA SYSTEMS CORP12.84%Add +3.5%6,082,646$1.42B$233.20No quote
3FOXTWENTY-FIRST CENTURY FOX INC12.77%Reduce -46.3%28,626,334$1.41B$49.27No quote
4STXSEAGATE TECHNOLOGY PLC11.45%Add +4.4%22,404,700$1.27B$56.47No quote
5KKRKKR & CO LP11.18%-49,700,000$1.24B$24.85No quote
6CBRECBRE GROUP INC8.61%-19,916,923$950.83M$47.74No quote
7MSMORGAN STANLEY8.03%Add +4.2%18,709,620$886.84M$47.40No quote
8TRNTRINITY INDS INC6.64%-21,407,891$733.44M$34.26No quote
9AWIARMSTRONG WORLD INDS INC NEW3.92%-6,852,612$433.09M$63.20No quote
10SLMSLM CORP3.90%Add +408.2%37,605,408$430.58M$11.45No quote
11VRXVALEANT PHARMACEUTICALS INTE3.79%Add +0.1%18,033,149$419.09MNo quoteNo quote
12AFIIQARMSTRONG FLOORING INC0.59%Add +0.1%4,614,787$64.79MNo quoteNo quote
13UFIUNIFI, INC.0.27%New925,000$29.32MNo quoteNo quote
14LINDLINDBLAD EXPEDITIONS HOLDINGS INC0.20%New1,691,300$22.41M$13.25No quote
15STRASTRAYER EDUCATION0.20%New193,457$21.86MNo quoteNo quote
16AESAES CORP0.19%New1,529,500$20.51M$13.41No quote
17EVAENVIVA PARTNERS LP0.18%New685,453$19.95MNo quoteNo quote